Company Focus

Vertex Pharmaceuticals

Latest Vertex Pharmaceuticals News

Vertex ups guidance again as results exceed estimates
Pharmaceutical
US biopharma Vertex Pharmaceuticals was trading nearly 2% higher during pre-market trading on Tuesday. This followed Vertex’s presentation of its third-quarter financial results and latest outlook for 2024 as a whole.   5 November 2024


Insights

Company Spotlight

Latest News & Features of interest to Vertex Pharmaceuticals

Latest Relevant Ones To Watch News

Relevant Ones to Watch Companies

Reset all filters
Refine Search